- Natural Cushings Disease Supplement for Dogs
- Order on Amazon
- Order on Walmart
BestFriends Biotechnics introduced their premier product, CushAway, in 2013 as a nutritional supplement specifically for aiding the treatment of Cushing’s disease. CushAway was developed by the founder of BestFriends Biotechnics in order to treat his own 12-year-old mixed-breed Golden Retriever that was suffering from Cushing’s disease.
After much research and trial and error, the patent-pending formula for CushAway was finalized. After finding no comparable products in the marketplace, the decision was made to manufacture and distribute CushAway.
The secondary purpose of BestFriends Biotechnics is to provide revenue for philanthropic and charitable endeavors focusing on the issue of shelter animals and senior dogs. BestFriends Biotechnics is a proud supporter of The Gray Muzzle Foundation and rescue organizations such as Hope for Paws.
A portion of the proceeds from every product sold by BestFriends Biotechnics is donated to a charitable foundation set up for this purpose.
BestFriends Biotechnics CEO
CushAway: effective, proven ingredients that provide a safe and cost-effective weapon in the fight against canine Cushing’s disease.
CushAway’s ingredients are recommended by the foremost experts in canine Cushing’s disease — the University of Tennessee College of Veterinary Medicine — as a first-line treatment. CushAway may be enough to keep your dog off pharmacological treatments altogether, or at least reduce your dependence on them.
CushAway is not only the most effective canine Cushing’s supplement — featuring three active ingredients that reduce the production or rapidly deplete corticosteroids (the root cause of Cushing’s disease) — it’s also one of the least expensive. Dose for dose, CushAway costs less than the most popular supplements and prescription medications used to treat Cushing’s disease in dogs.
CushAway carries a far lower risk of serious side effects compared to pharmaceutical treatments, which can include Addisonian crisis, adrenal necrosis, adrenal rupture, acute bleeding, related illness, and even death.
A 1999 Journal of the American Veterinary Medical Association study revealed that more than 50% of board-certified specialists would not treat a dog showing minimal clinical signs of Cushing’s disease due to the risk of severe side effects — particularly in older dogs.
